1,9-dideoxyforskolin has been researched along with docetaxel anhydrous in 1 studies
| Studies (1,9-dideoxyforskolin) | Trials (1,9-dideoxyforskolin) | Recent Studies (post-2010) (1,9-dideoxyforskolin) | Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) |
|---|---|---|---|---|---|
| 111 | 0 | 2 | 12,110 | 3,216 | 6,920 |
| Protein | Taxonomy | 1,9-dideoxyforskolin (IC50) | docetaxel anhydrous (IC50) |
|---|---|---|---|
| Kinesin-like protein KIF11 | Homo sapiens (human) | 0.0014 | |
| Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | 5.0119 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirst, BH; Hunter, J; Simmons, NL | 1 |
1 other study(ies) available for 1,9-dideoxyforskolin and docetaxel anhydrous
| Article | Year |
|---|---|
Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Colforsin; Docetaxel; Epithelium; Humans; Intestinal Absorption; Intestinal Mucosa; Membrane Glycoproteins; Nifedipine; Paclitaxel; Taxoids; Tumor Cells, Cultured; Verapamil; Vinblastine | 1993 |